Health Care: Drugs

Nivalis Therapeutics Inc (NVLS: NASDAQ)

$14.54 n/a | n/a%
08/31/15 - 04:00 PM ET
Company Cash Flow
Dec 2014
Cash Flow From Operating Activities
Net Income (Loss) -15.04M
Operating Gains/Losses 1.54K
Extraordinary Gains / Losses 0.00
(Increase) Decrease In Receivables 0.00
(Increase) Decrease in Inventories 0.00
(Increase) Decrease In Other Current Assets 0.00
(Decrease) Increase In Payables 258.25K
(Decrease) Increase In Other Current Liabilities 139.52K
(Increase) Decrease In Other Working Capital 0.00
Other Non-Cash Items -226.28K
Net Cash From Continuing Operations -14.45M
Net Cash From Discontinued Operations 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities -14.45M
Sale of Property, Plant & Equipment 0.00
Cash Used for Investing Activities
Sale of Short-Term Investments 0.00
Purchases of Property, Plant & Equipment -4.10K
Acquisitions 0.00
Purchases of Short-Term Investments 0.00
Other Cash from Investing Activities 0.00
Cash Provided by Financing Activities
Net Cash From Investing Activities -4.10K
Issuance of Debt 11.87M
Cash Used for Financing Activities
Issuance of Capital Stock 29.94M
Repayment of Long-Term Debt -3.14M
Repurchase of Capital Stock 0.00
Payment of Cash Dividends 0.00
Other Financing Charges, Net 2.50M
Net Cash From Financing Activities 41.17M
Effect of Exchange Rate Changes 0.00
Net Change in Cash & Cash Equivalents 26.71M

Portfolios with NVLS

Latest NVLS Headlines from TheStreet

More Financial News for NVLS

Press Releases for NVLS

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter